Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Preferred Stock Liabilities (2018)

Alector's (ALEC) quarterly Preferred Stock Liabilities came in at $210.5 million in Q4 2018, little changed quarter-over-quarter from $210.2 million in Q3 2018.

Analysis

Alector (ALEC) Preferred Stock Liabilities (2018) Analysis & Trends

Alector (ALEC) has reported Preferred Stock Liabilities for 1 consecutive years, with $210.5 million the latest figure, recorded in Q4 2018.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $210.5 million in Q4 2018; TTM through Dec 2018 was $210.5 million, a N/A change from a year earlier, with the FY2018 full-year figure at $210.5 million, up 171.69% from the prior year.
  • Preferred Stock Liabilities was $210.5 million for Q4 2018 at Alector, roughly flat from $210.2 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $210.5 million in Q4 2018 and troughed at $77.5 million in Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 Alector 274.68 Mn 101.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 210.52 Mn
Sep 30, 2018 210.17 Mn
Jun 30, 2018 147.57 Mn
Mar 31, 2018 77.49 Mn